This story examines how research that shows that certain cannabinoid compounds can block Covid-19 infections in human cells may eventually lead to new drug treatments. However there are many scientific, medical, regulatory and marketing hurdles to pass before that can happen.
Meanwhile and separately, cannabinoids’ anti-inflamatory properties may also point the way to other Covid-19 treatments.